Software development tools maker GitLab (NASDAQ:GTLB) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 29.1% year on year to $211.4
Online fashion resale marketplace ThredUp (NASDAQ:TDUP) fell short of the market’s revenue expectations in Q4 CY2024, with sales falling 17.4% year on
Identity management software maker Okta (OKTA) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 12.7% year on year to
The AI trade continued to falter on Monday, with Nvidia stock slumping into bear territory. Equities nosedived after President Trump reiterated plans for
Shares in BAE Systems, Rheinmetall and Leonardo all added to strong gains this year on Monday amid expectations of rising European defense spending.
Diagnostics company Guardant Health (NASDAQ:GH) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 30.2% year on year to $201.8 million.
Shares of digital media measurement and analytics provider DoubleVerify (NYSE:DV) jumped 10.4% in the afternoon session after the stock rebounded from
(Bloomberg) -- Sunnova Energy International Inc. shares plunged 71% as the company warned there’s substantial doubt it will remain in business. That came
Tariff fears and soft economic data have traders debating whether a recession is on the horizon.
Drugmaker AbbVie has agreed to license a weight-loss drug currently in development from Gubra for up to about $2.2 billion, marking its entry into the
